524516
BACPHAR
Start SIP
Invest Now
Start SIP in BACPHAR
Performance
- Low
- ₹41
- High
- ₹45
- 52 Week Low
- ₹27
- 52 Week High
- ₹48
- Open Price₹43
- Previous Close₹43
- Volume7,727
- 50 DMA₹38.11
- 100 DMA₹38.56
- 200 DMA₹37.64
Investment Returns
- Over 1 Month -1.98%
- Over 3 Month -7.26%
- Over 6 Month + 13.46%
- Over 1 Year -13.94%
Smart Investing Starts Here Start SIP with Bacil Pharma for Steady Growth!
Bacil Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 91.6
- PEG Ratio
- 1.4
- Market Cap Cr
- 58
- P/B Ratio
- 2.2
- Average True Range
- 2.96
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.24
- RSI
- 57.34
- MFI
- 70.58
Bacil Pharma Financials
Bacil Pharma Technicals
EMA & SMA
Current Price
₹40.62
-2.12
(-4.96%)
- Bearish Moving Average 3
- Bullish Moving Average 13
- 20 Day
- ₹38.62
- 50 Day
- ₹38.11
- 100 Day
- ₹38.56
- 200 Day
- ₹37.64
Resistance and Support
42.03
- R3 47.63
- R2 46.20
- R1 43.46
- S1 39.29
- S2 37.86
- S3 35.12
Bacil Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-09-05 | Others | Inter-alia, to consider 1. Fix Date, Place, Timing and Notice for 38th AGM of the Company. 2. Director Report of the Company for the Financial Year 2024-2025. 3. Other business matters. |
| 2025-08-25 | Others | Inter-alia, to consider 1. Discussion on Appointment of M/s Sarang Shivajirao Chavan & Associate as a Statutory Auditor of the Company. 2. Appointment of New Director. 3. Other business matters. |
| 2025-08-12 | Quarterly Results | |
| 2025-07-16 | Others | Inter-alia, to consider 1. Appointment of a new Executive Director and Chief Financial Officer of the Company. 2. Resignation of the present Chief Financial Officer. 3. Other business matters. |
Bacil Pharma F&O
About Bacil Pharma
- NSE Symbol
- BACPHAR
- BSE Symbol
- 524516
- ISIN
- INE711D01018
Similar Stocks to Bacil Pharma
Bacil Pharma FAQs
Bacil Pharma share price is ₹40 As on 11 January, 2026 | 04:20
The Market Cap of Bacil Pharma is ₹58.3 Cr As on 11 January, 2026 | 04:20
The P/E ratio of Bacil Pharma is 91.6 As on 11 January, 2026 | 04:20
The PB ratio of Bacil Pharma is 2.2 As on 11 January, 2026 | 04:20
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.